LOS ANGELES, CA / ACCESSWIRE / March 12, 2021 / AudioCardio, an innovative sound therapy and hearing training app, has officially announced the addition of three senior advisors to its advisory board. The three advisors include Kevin Liebe, AuD, President and CEO of Hearing Health & Technology Matters, Robert Traynor, , Ed.D., MBA, FNAP, President and CEO of Robert Traynor Audiology, LLC, and Tony Sulsona, Managing Director of Castle Group Consulting, LLC and former hearing industry Vice President of Sales of Bernafon US.
Together, AudioCardio’s new advisors will focus on guiding the company in designing and conducting studies, providing evidence based research and outcomes, distribution models to work with the professional hearing health market, and help drive education and awareness on AudioCardio’s “groundbreaking research and innovative solutions” that aim to address hearing loss and tinnitus.
AudioCardio CEO Chris Ellis says, “We are very excited to welcome Robert, Tony, and Kevin as advisors to AudioCardio. With nearly 100 years of combined experience, they bring invaluable experience from the hearing health industry that can help AudioCardio reach its goal of becoming the leading hearing therapy platform on the market. We will work closely with each advisor to ensure the safety, innovation, and performance of our technology and offerings to the broader market.”
The addition of these advisors comes as AudioCardio enters a new phase of growth with a currentcrowdfunding campaignon Republic which has seen over 160 investors participate to date. The company was also recently featured as part of the global series Meet The Drapers Season 4, won the 2020 Centre for Aging & Brain Health Innovation award, and a winner in the 2020 New Product and Technology Awards. Part of AudioCardio’s roadmap will be the continued focus on product innovation, research and distribution of their offering. The addition of these advisors will be an important element in putting AudioCardio in the best position to help people around the world.
“I’m excited to be working alongside AudioCardio,” says Tony Sulsona, “and advising the founders and executive team on global business development strategies in their quest to make direct hearing therapy easily accessible for millions of hearing-impaired individuals.”
“As doctors of audiology, Kevin and I look forward to providing our broad scope of academic, clinical, and product expertise and connections within the audiology community to help AudioCardio expand their reach into the hearing healthcare professional market,” says Robert Traynor.
AudioCardio is a mobile app that assesses your hearing and generates a personalized sound therapy (inaudible) designed to maintain and strengthen your hearing. It is a once a day, one hour sound therapy that stimulates the cells inside your ear. You can think of it like physical therapy for your hearing. The sound therapy is delivered using headphones or earbuds, is completely passive and runs in the background while you do other activities like listening to music, checking email and falling asleep.
AudioCardio’s threshold sound conditioning technology (TSC) has been clinically tested with the Stanford University School of Medicine. The study results on the effect of TSC on the improvement of hearing was published in May 2020 in the international journal Laryngoscope Investigative Otolaryngology, and the level of evidence, an indicator of reliability evaluation of TSC research, was evaluated as 1a, the highest level of CEBM (Centre for Evidence-based Medicine) classification by the University of Oxford.
About Kevin Liebe, AuD
Kevin Liebe, AuD, is President and CEO of Hearing Health & Technology Matters, a leading online resource for hearing professionals and consumers with hearing loss. He is the co-founder of Audiology Exclusive, a hearing industry consulting firm. As an audiologist, Kevin has experience in a variety of settings, including private practice, ENT, and industry. He is a past president and board member of the Washington State Academy of Audiology.
Kevin has a passion for disruptive and innovative technologies and currently serves as a Scientific Advisor to Neosensory, a Silicon Valley based startup pioneering experiences in sensory augmentation.
About Robert Traynor
For 46 years, Robert M. Traynor, Ed.D., MBA, FNAP, practiced audiology at his clinic in Greeley, Colorado where he provided intraoperative monitoring, diagnostic and rehabilitative treatment to hearing loss and tinnitus patients of all ages. He is President and CEO of Robert Traynor Audiology, LLC, a firm known for industry consulting, forensic audiology, hearing conservation as well as a co-founder of Audiology Exclusive, LLC, a group hearing industry consulting firm. For 17 years, he was the Senior International Audiology Consultant to a major hearing aid manufacturer based in Bern, Switzerland, providing training for domestic and international distributors as well as technical support to engineers and hearing scientists within the hearing aid research and development group.
As an academic, Dr. Traynor has served as an audiology program director and professor in various universities, including 21 years at the University of Florida. He currently serves as an Adjunct Professor of Audiology at Salus University and the University of Arkansas for Medical Sciences. Dr. Traynor has co-authored 3 editions of Strategic Practice Management, 100 papers, presented over 350 times and served state and national professional audiology organizations in various leadership capacities.
About Tony Sulsona
Tony is an accomplished executive with over 23 years of sales leadership, senior level management, and business development expertise at established and startup healthcare and medical device companies, with proven success executing commercialization and marketing initiatives and managing strategic stakeholder relationships.
His hearing healthcare experience spans 16 years as Vice President of Sales for Bernafon, LLC where he also served as Sales & Marketing Strategic Advisor and US Brand Strategy Think Tank delegate. Recently, Tony was the Managing Director for a Swiss medical IoT startup, and currently serves as Strategic Board Advisor for a healthcare & consumer marketing firm and as a senior sales and commercialization consultant for a healthcare advocacy consortium.
Media contact information
View source version on accesswire.com: